Shasun Pharmaceuticals Ltd.[Merged] - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 15	Mar ' 14	Mar ' 13	Mar ' 12	Mar ' 11

Sources of funds

Owner's fund

Equity share capital

12.03

11.33

11.33

11.03

9.71

Share application money

19.53

-

-

2.81

-

Preference share capital

-

-

-

-

-

Reserves & surplus

382.35

303.94

273.88

248.65

161.78

Loan funds

Secured loans

520.44

488.66

314.71

183.02

172.85

Unsecured loans

0.52

0.88

55.83

31.28

23.10

Total

934.87

804.81

655.74

476.79

367.44

Uses of funds

Fixed assets

Gross block

767.65

581.19

519.18

441.48

398.76

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

341.52

304.57

251.80

247.15

232.58

Net block

426.13

276.62

267.39

194.33

166.17

Capital work-in-progress

65.96

101.69

80.86

30.81

4.93

Investments

62.44

57.42

50.90

5.04

2.35

Net current assets

Current assets, loans & advances

764.50

711.00

516.01

482.14

391.24

Less : current liabilities & provisions

384.15

341.92

259.41

235.53

197.25

Total net current assets

380.35

369.08

256.60

246.61

193.99

Miscellaneous expenses not written

-

-

-

-

-

Total

934.87

804.81

655.74

476.79

367.44

Notes:

Book value of unquoted investments

68.83

57.42

50.90

5.04

2.35

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

261.60

222.48

173.09

291.43

352.96

Number of equity sharesoutstanding (Lacs)

601.24

566.24

566.24

551.24

485.45